VAX1 mutation associated with microphthalmia, corpus callosum agenesis and orofacial clefting-the first description of a VAX1 phenotype in humans.

Détails

Ressource 1Télécharger: 22095910_Postprint.pdf (1105.33 [Ko])
Etat: Public
Version: de l'auteur⸱e
ID Serval
serval:BIB_436F23A362DE
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
VAX1 mutation associated with microphthalmia, corpus callosum agenesis and orofacial clefting-the first description of a VAX1 phenotype in humans.
Périodique
Human Mutation
Auteur⸱e⸱s
Slavotinek A.M., Chao R., Vacik T., Yahyavi M., Vacik T., Abouzeid H., Bardakjian T., Schneider A., Shaw G., Sherr E.H., Lemke G., Youssef M., Schorderet D.F.
ISSN
1098-1004 (Electronic)
ISSN-L
1059-7794
Statut éditorial
Publié
Date de publication
2012
Peer-reviewed
Oui
Volume
33
Numéro
2
Pages
364-368
Langue
anglais
Notes
Publication types: JOURNAL ARTICLEPublication
Résumé
Vax1 and Vax2 have been implicated in eye development and the closure of the choroid fissure in mice and zebrafish. We sequenced the coding exons of VAX1 and VAX2 in 70 patients with anophthalmia/microphthalmia. In VAX1, we observed homozygosity for two successive nucleotide substitutions c.453G>A and c.454C>A, predicting p.Arg152Ser, in a proband of Egyptian origin with microphthalmia, small optic nerves, cleft lip/palate and corpus callosum agenesis. This mutation affects an invariant residue in the homeodomain of VAX1 and was absent from 96 Egyptian controls. It is likely that the mutation results in a loss of function, as the mutation results in a phenotype similar to the Vax1 homozygous null mouse. We did not identify any mutations in VAX2. This is the first description of a phenotype associated with a VAX1 mutation in humans and establishes VAX1 as a new causative gene for anophthalmia/microphthalmia. ©2011 Wiley Periodicals, Inc.
Pubmed
Web of science
Création de la notice
05/12/2011 10:51
Dernière modification de la notice
20/08/2019 14:47
Données d'usage